Wuxi AppTec
TOPIC
 / company

Wuxi AppTec

Wuxi AppTec
Wuxi AppTec
Wuxi AppTec is Asia's largest provider of contract pharmaceutical research, helping drug makers shorten their discovery and development procedures. Its platform is used by more than 6,000 customers, including biotech and pharmaceutical companies, research institutions, researchers, scientists and entrepreneurs in more than 30 countries. The company was founded by Ge Li, who also chairs Wuxi Biologics.
Chairman / President
Li Ge
CEO / Managing Director
Chen Minzhang
CFO / Finance Director
Shi Ming
Industry
Biopharmaceutical
Website
wuxiapptec.com
Headquarters address
288 Fute Zhong Road Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, China
Stock Code
SEHK:603259
SSE:603259
Year founded
2000
LATEST China Science NEWS
MORE China Science NEWS
Hong Kong stock market

Hong Kong stocks climb as yuan strengthens and investors broaden focus beyond US

Hang Seng Index advances as investors shift focus, boosting Asian equities, with pharmaceutical and healthcare shares leading gainers.

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

Why US lawmakers killed a proposal targeting science efforts with China

US researchers and industry experts warn that even the revised version may have unintended consequences.

videocam
Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement